Hervé Brailly, Chairman of the Supervisory Board, co-founded Innate Pharma in 1999 and chaired its Executive Committee until December 30, 2016.
Hervé Brailly was previously a researcher at Immunotech SA, a biotechnology start up acquired in 1995 by Beckman-Coulter (1986-1994), where he later became responsible for marketing, business development and R&D, as well as the business activities in China (1994-1998). From 1998, Mr Brailly was the director of a business unit of the company with 65 employees and annual sales of 30 million U.S. dollars.
Hervé Brailly is a graduate of the Ecole des Mines de Paris (1983) and a Doctor of Immunology, with a specialization in immuno-pharmacology.
Hervé Brailly is member of the development council of the ”Marseille Provence Metropole”, the Strategy and Prospects Committee of Aix Marseille University and the Investment Committee of SATT Sud Est. He is also member of the Executive committee and treasury of Eurobiomed.
Eurobiomed is the catalyst of the health sector, from basic research to the market, for the benefit of patients and of the southern France’s economic fabric. Eurobiomed also carries Marseille Immunopôle cluster, of which Innate Pharma is a founding member.